Crinetics Pharmaceuticals, Inc. (CRNX)
35.55
-0.46
(-1.28%)
USD |
NASDAQ |
May 29, 16:00
35.54
-0.01
(-0.03%)
Pre-Market: 20:00
Crinetics Pharmaceuticals Total Assets (Quarterly) : 1.401B for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Pfizer Inc. | 207.62B |
| Amneal Pharmaceuticals, Inc. | 3.540B |
| Aquestive Therapeutics, Inc. | 141.12M |
| Merck & Co., Inc. | 128.68B |
| Nektar Therapeutics | 763.27M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 120.68M |
| Shareholders Equity (Quarterly) | 1.281B |
| Debt to Equity Ratio | 0.0374 |
| Current Ratio | 18.60 |
| Net Debt Paydown Yield | 0.02% |